T.Man Pharmaceutical Public Company Limited earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is attractive. The owner-earnings multiple stands at 10.1×; owner earnings: the cash an owner could take out each year.
Growth is moderate; the safety picture is sturdy. The company scores 18/20 on our value-creation score: strong value creator.
Flags to be aware of: Some accounting patterns deserve a closer look. Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202675
67
2026
All-time high
75
Mar 2026
All-time low
67
Jun 2026
Average rank
71
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
61
—
—
—
Price/Earnings
69
—
—
—
Price/Book
52
—
—
—
Dividend Yield
81
—
—
—
Value (overall)
82
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.